Royce & Associates’s CONMED CNMD Stock Holding History

Royce & Associates’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-30,000	Closed	-$2.36M	–	1008
2020 Q3	$2.36M	Hold	30,000	–	–	0.03%	651
2020 Q2	$2.16M	Hold	30,000	–	–	0.02%	653
2020 Q1	$1.72M	Buy	30,000 +1,000	+3%	+$92.2K	0.02%	633
2019 Q4	$3.24M	Hold	29,000	–	–	0.03%	594
2019 Q3	$2.79M	Hold	29,000	–	–	0.03%	632
2019 Q2	$2.48M	Sell	29,000 -475	-2%	-$39K	0.02%	675
2019 Q1	$2.45M	Buy	29,475 +52	+0.2%	+$3.78K	0.02%	682
2018 Q4	$1.89M	Buy	29,423 +5,013	+21%	+$343K	0.02%	747
2018 Q3	$1.93M	Buy	24,410 +24,130	+8,618%	+$1.87M	0.01%	833
2018 Q2	$20K	Buy	280 +97	+53%	+$6.6K	﹤0.01%	1122
2018 Q1	$12K	Sell	183 -59	-24%	-$3.52K	﹤0.01%	1147
2017 Q4	$12K	Buy	242 +22	+10%	+$1.15K	﹤0.01%	1147
2017 Q3	$12K	Buy	+220	New	+$11K	﹤0.01%	1128
2015 Q4	–	Sell	-81,500	Closed	-$3.89M	–	1129
2015 Q3	$3.89M	Hold	81,500	–	–	0.02%	705
2015 Q2	$4.75M	Hold	81,500	–	–	0.02%	744
2015 Q1	$4.12M	Sell	81,500 -700	-0.9%	-$34.3K	0.02%	784
2014 Q4	$3.7M	Hold	82,200	–	–	0.01%	849
2014 Q3	$3.03M	Hold	82,200	–	–	0.01%	922
2014 Q2	$3.63M	Hold	82,200	–	–	0.01%	931
2014 Q1	$3.57M	Hold	82,200	–	–	0.01%	950
2013 Q4	$3.49M	Hold	82,200	–	–	0.01%	967
2013 Q3	$2.79M	Hold	82,200	–	–	0.01%	993
2013 Q2	$2.57M	Buy	+82,200	New	+$2.67M	0.01%	1015

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Royce & Associates's CNMD Position: Q4 2020 in Review

Royce & Associates sold out of CONMED (CNMD) in Q4 2020, closing a stake of 30,000 shares — an estimated $2.36M sold.

Royce & Associates first reported a position in CNMD in Q2 2013 and held it in 23 quarters. The position peaked at $4.75M in Q2 2015. 249 funds tracked by Wall St. Rank hold CNMD as of Q4 2020.

Royce & Associates reported no remaining CONMED position as of Q4 2020 after selling out during the quarter.
Royce & Associates sold 30,000 CONMED shares in Q4 2020, an estimated $2.36M.
Royce & Associates first reported a position in CONMED in Q2 2013 and held it in 23 quarters.
Royce & Associates's CONMED position peaked at $4.75M in Q2 2015.
249 funds tracked by Wall St. Rank held CONMED as of Q4 2020.

Based on Royce & Associates's 13F filing for Q4 2020, filed 8 Feb 2021.